With early diagnosis, expert surgical care, and intensive support, many of the babies with critical congenital heart disease ...

Emma Willis opens up on ‘terrifying’ heart diagnosis ahead of new Radio 2 gig - The broadcaster unknowingly lived with the ...

A baby was left fighting for her life with a collapsed lung after being sent home FIFTEEN times by doctors who dismissed the ...

A Hermiston, Oregon, family is seeking support for end-of-life care for their 2-year-old son, Avery Henderson, who was born ...

We existed in our own world that day, absorbing information we never wanted to learn. At one point, while I was crying ...

A Carnegie Mellon University-led team has received up to $28.5 million to develop a functional, 3D bioprinted liver for ...

TO most, rubella sounds like a virus from a bygone era – something you associate with grainy black-and-white photos of ...

Wave II clinical study will evaluate THRV-1268, Thryv’s oral SGK1 inhibitor, in adults with Long QT Syndrome Type 2. Wave II ...

In a state that had legislated its commitment to life, Graham spent her final days struggling to find anyone to save hers.

A baby girl is battling for her life with a collapsed lung after her parents claim doctors repeatedly dismissed desperate ...

MONTREAL, /CNW/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company advancing novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for inherited cardiac arrhythmias, ...

Launched KOMZIFTI™ (ziftomenib), first and only once-daily, oral menin inhibitor approved for adults with R/R NPM1-mutated AML – – $2.1 million ...